Skip to main content
. Author manuscript; available in PMC: 2020 Mar 7.
Published in final edited form as: Mol Cell. 2018 Dec 4;73(5):1001–1014.e8. doi: 10.1016/j.molcel.2018.11.028

Fig 7– OA impacts αS inclusion formation, tetramer:monomer ratio and pS129.

Fig 7–

A) Exogenous OA increases αS inclusions in αS3K-expressing neuroblastoma cells. *p<0.05 ****p<0.0001 (one way Anova). B) SCD1 knockdown decreases αS inclusions in αS3K-expressing neuroblastoma cells. C: control (scrambled DsiRNA). ***p<0.0005; ****p<0.0001. C) SCD inhibition decreases αS inclusions. *p<0.05 ****p<0.0001 (one way Anova). D) SCD inhibition decreases αS inclusions (microscopy) in αS3K-expressing neuroblastoma cells. E&F) SCD1 inhibition increases 60kDa αS:14kDa αS in αS3K-expressing neuroblastoma cells. *non-specific band (Perrin et al., 2003).*p<0.05 **p<0.01. G) SCD inhibition decreases pS129 αS: total αS. n=6. *p<0.05 ***p<0.005,t-test. H) SCD1 inhibition increases 60kDa αS:14kDa αS and 80kDa αS: 14kDa αS in fPD E46K-expressing neuroblastoma cells. N=2, n=6. I) SCD1 inhibition decreases pS129 αS: total αS in E46K-expressing cells. N=2, n=10. **p<0.01, t-test.